Physician profile
Ivan E Coronado
NPI 1790705721
$14,180.39
in general payments reported to CMS, 2019-2025
43 companies · $1,798 in 2025
The $1,798 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,652 · 2020: $662 · 2021: $977 · 2022: $2,912 · 2023: $2,772 · 2024: $1,408 · 2025: $1,798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,977.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,406.64 | 2019-2025 | Aveir, Cardiomems, Mitraclip |
| Boston Scientific Corporation | $1,604.65 | 2019-2025 | Watchman Flx, Watchman, Watchman Access System |
| Atricure, INC. | $1,601.03 | 2022-2024 | |
| Medtronic, INC. | $1,063.53 | 2021-2024 | Corevalve Evolut R, Micra, Intellis Adaptivestim |
| Astrazeneca Pharmaceuticals Lp | $907.37 | 2020-2025 | Farxiga, Wainua |
| Pfizer INC. | $723.10 | 2019-2025 | |
| Edwards Lifesciences Corporation | $699.82 | 2021-2025 | |
| Amgen INC. | $695.50 | 2019-2025 | Repatha, Prolia, Evenity |
| Medtronic Vascular, INC. | $423.53 | 2019-2020 | |
| Abiomed | $386.01 | 2023 | Impella |
| Novo Nordisk INC | $373.02 | 2021-2025 | Wegovy, Ozempic |
| Heartflow, INC. | $337.31 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $288.55 | 2020-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $268.54 | 2019-2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $256.47 | 2022-2024 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Coronado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.